Atlas Trials

To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19

Clinical trial NCT04709328 · NOT_YET_RECRUITING

Trial details

NCT number
NCT04709328
Sponsor
Sinocelltech Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19SARS-CoV-2
Start date
2021-03-28
Primary completion
2022-01-01
Enrollment
690

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.